The Food & Drug Administration (FDA) has fully approved the Pfizer Bio-N-Tech COVID-19 vaccine for people 16 and older — making it the first to be fully licensed for use in the United States. We anticipate full approval for the Moderna and Johnson & Johnson (J&J) COVID-19 Vaccines for adults as soon as the FDA has conducted its final analysis. For more information, please click the button “FDA Fully Approved Pfizer-BioNTech Vaccine (Comirnaty) Information.”
The FDA has authorized a third shot of the Pfizer and Moderna vaccines as a booster shot. These shots are now available to immunocompromised people and are anticipated to be available to Pfizer and Moderna-vaccinated people eight months after the date of their second shot, beginning around September 20. The J&J vaccine data is currently being evaluated for booster shot efficacy and information on this vaccine’s booster shot will be provided when available. For more information about the booster shots, visit “Vaccine FAQ” below.
Information is flowing at a rapid pace as the COVID-19 coronavirus outbreak continues to evolve. We are closely monitoring updates from the World Health Organization (WHO), the infection rate from the Centers for Disease Control and Prevention (CDC), and virus tracking systems. We have established an emergency command center to monitor resources and plan our response.
Our expert clinicians regularly care for patients with severe respiratory illnesses and other infectious diseases. Our clinicians follow specific procedures using the tools and techniques in place to protect themselves, including the use of personal protective equipment (PPE).